MGI Tech received China NMPA approval for its DNBSeq-T1+ sequencer, clearing the platform for deployment into the Chinese clinical market. MGI said the benchtop system can produce up to 1.2 terabases of data per day across two flow cells and is positioned for applications including cancer diagnostics, rare disease testing, and genetic screening. In parallel, a cryo-EM service expansion pointed to continued infrastructure buildout for antibody discovery and biologics development. FairJourney Bio opened a cryo-electron microscopy structural biology facility in San Diego featuring 300 kV cryo-EM systems aimed at atomic-resolution characterization of antibody-target complexes. Both items signal continued investment in diagnostics and structural biology capabilities that can reduce timelines and improve decision-making in discovery pipelines.